tibolone has been researched along with Disease Models, Animal in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.69) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (69.23) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
De Nicola, AF; Garay, LI; García Segura, LM; Lima, A; Mancino, DNJ; Roig, P | 1 |
Cline, JM; Hofling, M; Ma, L; Masironi, B; Sahlin, L; von Schoultz, B | 1 |
Carvalho, AC; Fernandes, GV; Granjeiro, JM; Guzmán-Silva, MA; Henriques, HN; Lima, I; Lopes, RT; Oliveira, DF; Pantaleão, JA | 1 |
Biskobing, DM; Downs, R; Novy, AM | 1 |
Anthony, MS; Clarkson, TB; Mikkola, TS; St Clair, RW | 2 |
Ascaso, C; Casals, E; Castelo-Branco, C; Colodrón, M; Escaramís, G; Mercadé, I; Ordi, J; Sanjuán, A; Vanrell, JA; Vicente, JJ | 1 |
Cui, Y; Liu, H; Ning, Z; Qing, X; Wu, C; Yang, J; Yu, S; Zhao, D | 1 |
Christiansen, C; Gambacciani, M; Genazzani, AR; Schneider, HP | 1 |
Ederveen, AG; Kloosterboer, HJ; Quaijtaal, JH; Spanjers, CP | 1 |
Ang, WC; Farrell, E; Vollenhoven, B | 1 |
Deckers, GH; Schot, LP; Schuurs, AH; Verheul, HA | 1 |
2 review(s) available for tibolone and Disease Models, Animal
Article | Year |
---|---|
Novel therapeutic options for osteoporosis.
Topics: Animals; Controlled Clinical Trials as Topic; Diphosphonates; Disease Models, Animal; Evidence-Based Medicine; Fractures, Spontaneous; Glycoproteins; Humans; Ibandronic Acid; Imidazoles; Norpregnenes; Osteoporosis; Osteoprotegerin; Piperidines; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Selective Estrogen Receptor Modulators; Thiophenes; Zoledronic Acid | 2002 |
Effect of hormone replacement therapies and selective estrogen receptor modulators in postmenopausal women with uterine leiomyomas: a literature review.
Topics: Animals; Disease Models, Animal; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Uterine Neoplasms | 2001 |
11 other study(ies) available for tibolone and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Tibolone restrains neuroinflammation in mouse experimental autoimmune encephalomyelitis.
Topics: Animals; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Inflammation; Mice; Mice, Inbred C57BL; Neuritis; Neuroprotective Agents; Norpregnenes; Remission Induction | 2022 |
Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast.
Topics: Animals; Breast; Disease Models, Animal; Drug Therapy, Combination; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Longitudinal Studies; Macaca fascicularis; Medroxyprogesterone; Norpregnenes; Ovariectomy; Receptors, Progesterone | 2008 |
Influence of estrogen deficiency and tibolone therapy on trabecular and cortical bone evaluated by computed radiography system in rats.
Topics: Animals; Bone Density; Disease Models, Animal; Epidemiologic Methods; Estrogen Receptor Modulators; Estrogens; Female; Femur; Image Processing, Computer-Assisted; Norpregnenes; Ovariectomy; Radiography; Rats; Rats, Wistar; Tibia | 2012 |
Comparison of tibolone and conjugated equine estrogens effects on carotid artery atherosclerosis of postmenopausal monkeys.
Topics: Animals; Carotid Artery Diseases; Carotid Artery, Common; Carotid Artery, Internal; Cholesterol, HDL; Cholesterol, VLDL; Diet, Atherogenic; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Lipoproteins, LDL; Macaca fascicularis; Medroxyprogesterone Acetate; Norpregnenes; Postmenopause; Time; Vascular Patency | 2002 |
Effects of estradiol, cyproterone acetate, tibolone and raloxifene on uterus and aorta atherosclerosis in oophorectomized cholesterol-fed rabbits.
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol, Dietary; Cyproterone Acetate; Disease Models, Animal; Estradiol; Estrogen Replacement Therapy; Female; Norpregnenes; Ovariectomy; Rabbits; Raloxifene Hydrochloride; Uterus | 2003 |
Serum cholesterol efflux potential is an independent predictor of coronary artery atherosclerosis.
Topics: Animals; Apolipoprotein A-I; Arteries; Biomarkers; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Coronary Artery Disease; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Estrogen Receptor Modulators; Female; Fibroblasts; Haplorhini; Models, Cardiovascular; Multivariate Analysis; Norpregnenes; Observer Variation; Predictive Value of Tests; Skin; Statistics as Topic; Tunica Intima; Women's Health | 2003 |
A comparative study of efficacy of tibolone and simvastatin on atherosclerosis in ovariectomized cholesterol-fed rabbits.
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Diet, Atherogenic; Disease Models, Animal; DNA Primers; Estrogen Receptor Modulators; Female; Hypercholesterolemia; Norpregnenes; Ovariectomy; Polymerase Chain Reaction; Rabbits; Receptors, Estrogen; Receptors, LDL; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Simvastatin | 2005 |
Postmenopausal osteoporosis: therapeutic options.
Topics: Age Factors; Anabolic Agents; Animals; Bone Density; Calcium; Contraceptives, Oral; Diphosphonates; Disease Models, Animal; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Norpregnenes; Organometallic Compounds; Osteoporosis, Postmenopausal; Risk Factors; Selective Estrogen Receptor Modulators; Spinal Fractures; Thiophenes; Vitamin D | 2005 |
Effect of 16 months of treatment with tibolone on bone mass, turnover, and biomechanical quality in mature ovariectomized rats.
Topics: Alkaline Phosphatase; Amino Acids; Anabolic Agents; Animals; Biomarkers; Bone Density; Creatinine; Disease Models, Animal; Female; Femur; Liver; Norpregnenes; Osteocalcin; Osteoporosis; Ovariectomy; Rats; Rats, Wistar; Tibia; Time Factors | 2001 |
Effects of tibolone, lynestrenol, ethylestrenol, and desogestrel on autoimmune disorders in NZB/W mice.
Topics: Anabolic Agents; Animals; Autoimmune Diseases; Desogestrel; Disease Models, Animal; Ethylestrenol; Female; Lynestrenol; Male; Mice; Mice, Inbred NZB; Norpregnenes; Organ Size; Spleen; Submandibular Gland; Thymus Gland; Virilism | 1986 |